“`html
On October 24, 2025, Citigroup reaffirmed its Buy recommendation for Rentokil Initial (OTCPK:RKLIF). The average one-year price target for the company is projected at $5.77 per share, representing a potential upside of 10.14% from its latest closing price of $5.24 per share.
Rentokil Initial’s estimated annual revenue is $5.822 billion, reflecting a growth of 5.20%. The projected annual non-GAAP earnings per share (EPS) is 0.28. Institutional ownership decreased by 6.25% in the last quarter, with a total of 45 funds reporting positions in Rentokil Initial. Total shares owned by these institutions rose by 3.05% to 92.679 million shares.
“`
